6534 Stock Overview
CH Biotech R&D Co., Ltd., develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
CH Biotech R&D Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$82.90 |
| 52 Week High | NT$114.50 |
| 52 Week Low | NT$71.70 |
| Beta | 0.43 |
| 1 Month Change | -4.71% |
| 3 Month Change | 0.73% |
| 1 Year Change | 1.97% |
| 3 Year Change | 63.52% |
| 5 Year Change | -10.41% |
| Change since IPO | 2.61% |
Recent News & Updates
Recent updates
CH Biotech R&D (GTSM:6534) Takes On Some Risk With Its Use Of Debt
Apr 05
A Look At CH Biotech R&D's (GTSM:6534) Share Price Returns
Mar 18Are CH Biotech R&D Co., Ltd.'s (GTSM:6534) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Feb 09
Returns On Capital At CH Biotech R&D (GTSM:6534) Paint An Interesting Picture
Jan 11Does CH Biotech R&D (GTSM:6534) Have A Healthy Balance Sheet?
Dec 15Tread With Caution Around CH Biotech R&D Co., Ltd.'s (GTSM:6534) 1.8% Dividend Yield
Nov 24Shareholder Returns
| 6534 | TW Chemicals | TW Market | |
|---|---|---|---|
| 7D | -2.1% | -4.1% | -5.7% |
| 1Y | 2.0% | -15.1% | 23.8% |
Return vs Industry: 6534 exceeded the TW Chemicals industry which returned -15.1% over the past year.
Return vs Market: 6534 underperformed the TW Market which returned 23.8% over the past year.
Price Volatility
| 6534 volatility | |
|---|---|
| 6534 Average Weekly Movement | 4.3% |
| Chemicals Industry Average Movement | 3.4% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.5% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6534 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6534's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Cho-Chun Huang | www.chbio.com |
CH Biotech R&D Co., Ltd., develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally. It offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd.
CH Biotech R&D Co., Ltd. Fundamentals Summary
| 6534 fundamental statistics | |
|---|---|
| Market cap | NT$8.52b |
| Earnings (TTM) | NT$463.29m |
| Revenue (TTM) | NT$1.51b |
18.4x
P/E Ratio5.6x
P/S RatioIs 6534 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6534 income statement (TTM) | |
|---|---|
| Revenue | NT$1.51b |
| Cost of Revenue | NT$254.73m |
| Gross Profit | NT$1.26b |
| Other Expenses | NT$796.81m |
| Earnings | NT$463.29m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.51 |
| Gross Margin | 83.18% |
| Net Profit Margin | 30.58% |
| Debt/Equity Ratio | 22.8% |
How did 6534 perform over the long term?
See historical performance and comparison